Glutathione S-transferase M1 polymorphism and coronary heart disease susceptibility: A meta-analysis involving 47,596 subjects

Heart Lung and Circulation

Volumn 23, Issue 6, 2014, Pages 578-585

  Zhou, Donghui ^a   Hu, Weina ^a   Wang, Qi ^a   Jin, Yuanzhe ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Coronary heart disease; Gstm1; Meta analysis; Polymorphism; Smoking

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE TRANSFERASE;

ARTICLE; ASIAN; CARDIOVASCULAR RISK; CAUCASIAN; DISEASE PREDISPOSITION; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GLUTATHIONE TRANSFERASE M1 GENE; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; SMOKING; SYSTEMATIC REVIEW; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; ENZYMOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; META ANALYSIS;

CASE-CONTROL STUDIES; CORONARY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; POLYMORPHISM, GENETIC;

EID: 84904563609     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2014.01.003     Document Type: Article

References (39)

1. Gheorghiade M, Sopko G, De Luca L, Velazquez EJ, Parker JD, Binkley PF, et al. Navigating the crossroads of coronary artery disease and heart failure. Circulation 2006;114:1202-13.
2. Stocker R, Keaney Jr JF. Role of oxidative modifications in atherosclerosis. Physiological Reviews 2004;84:1381-478.
3. Liebson PR, Amsterdam EA. Prevention of coronary heart disease. Part I. Primary prevention. Disease-a-month DM 1999;45:497-571.
4. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Critical reviews in Biochemistry and Molecular Biology 1995;30:445-600.
5. Hanna E, MacLeod S, Vural E, Lang N. Genetic deletions of glutathione-S-transferase as a risk factor in squamous cell carcinoma of the larynx: a preliminary report. American Journal of Otolaryngology 2001;22:121-3.
6. Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000;61:154-66.
7. Attia J, Thakkinstian A, D'Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. Journal of Clinical Epidemiology 2003;56:297-303.
8. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 1959;22:719-48.
9. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-88.
10. Hayek T, Stephens JW, Hubbart CS, Acharya J, Caslake MJ, Hawe E, et al. A common variant in the glutathione S transferase gene is associated with elevated markers of inflammation and lipid peroxidation in subjects with diabetes mellitus. Atherosclerosis 2006;184:404-12.
11. Kim SJ, Kim MG, Kim KS, Song JS, Yim SV, Chung JH. Impact of glutathione S-transferase M1 and T1 gene polymorphisms on the smoking-related coronary artery disease. Journal of Korean Medical Science 2008;23:365-72.
12. Li R, Boerwinkle E, Olshan AF, Chambless LE, Pankow JS, Tyroler HA, et al. Glutathione S-transferase genotype as a susceptibility factor in smoking-related coronary heart disease. Atherosclerosis 2000;149: 451-62.
13. Maciel SS, Pereira Ada C, Silva GJ, Rodrigues MV, Mill JG, Krieger JE. Association between glutathione S-transferase polymorphisms and triglycerides and HDL-cholesterol. Atherosclerosis 2009;206:204-8.
14. Manfredi S, Calvi D, del Fiandra M, Botto N, Biagini A, Andreassi MG. Glutathione S-transferase T1- and M1-null genotypes and coronary artery disease risk in patients with Type 2 diabetes mellitus. Pharmacogenomics 2009;10:29-34.
15. Martin NJ, Collier AC, Bowen LD, Pritsos KL, Goodrich GG, Arger K, et al. Polymorphisms in the NQO1, GSTT and GSTM genes are associated with coronary heart disease and biomarkers of oxidative stress. Mutation Research 2009;674:93-100.
16. Masetti S, Botto N, Manfredi S, Colombo MG, Rizza A, Vassalle C, et al. Interactive effect of the glutathione S-transferase genes and cigarette smoking on occurrence and severity of coronary artery risk. J Mol Med (Berl) 2003;81:488-94.
17. Norskov MS, Frikke-Schmidt R, Loft S, Sillesen H, Grande P, Nordestgaard BG, et al. Copy number variation in glutathione S-transferases M1 and T1 and ischemic vascular disease: four studies and meta-analyses. Circulation Cardiovascular Genetics 2011;4:418-28.
18. Olshan AF, Li R, Pankow JS, Bray M, Tyroler HA, Chambless LE, et al. Risk of atherosclerosis: interaction of smoking and glutathione S-transferase genes. Epidemiology 2003;14:321-7.
19. Palmer CN, Young V, Ho M, Doney A, Belch JJ. Association of common variation in glutathione S-transferase genes with premature development of cardiovascular disease in patients with systemic sclerosis. Arthritis and Rheumatism 2003;48:854-5.
20. Phulukdaree A, Khan S, Moodley D, Chuturgoon AA. GST polymor-phisms and early-onset coronary artery disease in young South African Indians. South African Medical Journal Suid-Afrikaanse tydskrif vir geneeskunde 2012;102:627-30.
21. Salama SA, Au WW, Hunter GC, Sheahan RG, Badary OA, Abdel-Naim AB, et al. Polymorphic metabolizing genes and susceptibility to atherosclerosis among cigarette smokers. Environmental and Molecular Mutagenesis 2002;40:153-60.
22. Tamer L, Ercan B, Camsari A, Yildirim H, Cicek D, Sucu N, et al. Glutathione S-transferase gene polymorphism as a susceptibility factor in smoking-related coronary artery disease. Basic Research in Cardiology 2004;99:223-9.
23. Taspinar M, Aydos S, Sakiragaoglu O, Duzen IV, Yalcinkaya A, Oztuna D, et al. Impact of genetic variations of the CYP1A1, GSTT1, and GSTM1 genes on the risk of coronary artery disease. DNA and Cell Biology 2012; 31:211-8.
24. Wang LS, Tang JJ, Tang NP, Wang MW, Yan JJ, Wang QM, et al. Association of GSTM1 and GSTT1 gene polymorphisms with coronary artery disease in relation to tobacco smoking. Clinical Chemistry and Laboratory Medicine CCLM/FESCC 2008;46:1720-5.
25. Wang XL, Greco M, Sim AS, Duarte N, Wang J, Wilcken DE. Glutathione S-transferase mu1 deficiency, cigarette smoking and coronary artery disease. Journal of Cardiovascular Risk 2002;9:25-31.
26. Wilson MH, Grant PJ, Hardie LJ, Wild CP. Glutathione S-transferase M1 null genotype is associated with a decreased risk of myocardial infarction. FASEB Journal official publication of the Federation of American Societies for Experimental Biology 2000;14:791-6.
27. Wilson MH, Grant PJ, Kain K, Warner DP, Wild CP. Association between the risk of coronary artery disease in South Asians and a deletion polymorphism in glutathione S-transferase M1. Biomarkers: Biochemical Indicators of Exposure. Response and Susceptibility to Chemicals 2003;8:43-50.
28. Evans DA, Seidegard J, Narayanan N. The GSTM1 genetic polymor-phism in healthy Saudi Arabians and Filipinos, and Saudi Arabians with coronary atherosclerosis. Pharmacogenetics 1996;6:365-7.
29. Abu-Amero KK, Al-Boudari OM, Mohamed GH, Dzimiri N. T null and M null genotypes of the glutathione S-transferase gene are risk factor for CAD independent of smoking. BMC Medical Genetics 2006;7:38.
30. Bazo AP, Salvadori Jr D, Salvadori RA, Sodre LP, da Silva GN, de Camargo EA, et al. DNA repair gene polymorphism is associated with the genetic basis of atherosclerotic coronary artery disease. Cardiovascular Pathology: the Official Journal of the Society for Cardiovascular Pathology 2011;20:e9-15.
31. Cornelis MC, El-Sohemy A, Campos H. GSTT1 genotype modifies the association between cruciferous vegetable intake and the risk of myocardial infarction. The American Journal of Clinical Nutrition 2007;86:752-8.
32. Girisha KM, Gilmour A, Mastana S, Singh VP, Sinha N, Tewari S, et al. T1 and M1 polymorphism in glutathione S-transferase gene and coronary artery disease in North Indian population. Indian Journal of Medical Sciences 2004;58:520-6.
33. Yeh H-L, Kuo L-T, Sung F-C, Chiang C-W, Yeh C-C. GSTM1, GSTT1, GSTP1, and GSTA1 genetic variants are not associated with coronary artery disease in Taiwan. Gene 2013.
34. Wang J, Zou L, Huang S, Lu F, Lang X, Han L, et al. Genetic polymorphisms of glutathione S-transferase genes GSTM1, GSTT1 and risk of coronary heart disease. Mutagenesis 2010;25:365-9.
35. Ioannidis JP, Patsopoulos NA, Evangelou E. Uncertainty in heterogeneity estimates in meta-analyses. BMJ 2007;335:914-6.
36. Benowitz NL. Cigarette smoking and cardiovascular disease: patho-physiology and implications for treatment. Progress in Cardiovascular Diseases 2003;46:91-111.
37. Bridges BA. The possible involvement of somatic mutations in the development of atherosclerotic plaques. Atherosclerosis 1991;89:255-61.
38. Yamaguchi Y, Matsuno S, Kagota S, Haginaka J, Kunitomo M. Oxidants in cigarette smoke extract modify low-density lipoprotein in the plasma and facilitate atherogenesis in the aorta of Watanabe heritable hyperlipidemic rabbits. Atherosclerosis 2001;156:109-17.
39. Sarkar R, Gelabert HA, Mohiuddin KR, Thakor DK, Santibanez-Gallerani AS. Effect of Cigarette Smoke on Endothelial Regeneration in Vivo and Nitric Oxide Levels. Journal of Surgical Research 1999;82: 43-7.